Skip to main content

Mireia Armengol Alsina

Institutions of which they are part

Main researcher
Maternal and Fetal Medicine
Vall Hebron Institut de Recerca

Mireia Armengol Alsina

Institutions of which they are part

Main researcher
Maternal and Fetal Medicine
Vall Hebron Institut de Recerca

Projects

Marcadores angiogénicos revelados frente a ocultos para confirmar la preeclampsia a término: un ensayo clínico abierto, controlado y aleatorizado

IP: Erika Bonacina
Collaborators: Mireia Armengol Alsina
Funding agency: Instituto de Salud Carlos III
Funding: 51875
Reference: PI24/01222
Duration: 01/01/2025 - 31/12/2027

Manejo de los fetos con retraso de crecimiento intrauterino precoz: Factores angiogénicos versus Doppler feto-materno (early GRAFD Trial).

IP: Manel Mendoza Cobaleda
Collaborators: Mireia Armengol Alsina, Pablo García Manau, Erika Bonacina
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI22/00051
Duration: 01/01/2023 - 30/06/2027

Cribado de preeclampsia en la gestación gemelar

IP: Carlota Rodó Rodríguez
Collaborators: Mireia Armengol Alsina, Pablo García Manau, Berta Serrano Sanchez, Francisco Barranco Martinez
Funding agency: Instituto de Salud Carlos III
Funding: 162140
Reference: PI21/00601
Duration: 01/01/2022 - 30/06/2026

A dual liquid biopsy strategy in endometrial cancer: evaluation of risk of recurrence and pesonalized therapy.

IP: Antonio Gil Moreno
Collaborators: Vicente Bebia Conesa, Angel García Jiménez, Carina Masferrer Ferragutcasas, Ana Mazaltob Oaknin benzaquen, Montserrat Cubo Abert, Marta Rebull Santamaria, Mireia Armengol Alsina, Melek Denizli
Funding agency: Instituto de Salud Carlos III
Funding: 209330
Reference: PI20/01566
Duration: 01/01/2021 - 31/12/2023

Related news

Vall d’Hebron is part of the Consorcio INTERCOVID, which has analyzed over 6,500 pregnancies in 18 countries and observed a significant reduction in the risk of preeclampsia associated with vaccination.

Vall d’Hebron has taken part in a clinical trial whose results show improvements in endometrial regeneration and reproductive outcomes in patients with Asherman syndrome who had not responded to previous surgery.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Carla Cisneros Sanchez

Carla Cisneros Sanchez

Pediatric Neurology
Read more
Montserrat Murillo Andres

Montserrat Murillo Andres

Administration and Management
Pneumology
Read more
Emma Francés Rabanal

Emma Francés Rabanal

Research technician
Pneumology
Read more
Margarita Navarro Pérez

Margarita Navarro Pérez

Administration and Management
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.